Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Eurobio Scientific    ALERS   FR0013240934

EUROBIO SCIENTIFIC (ALERS)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 07/13 05:35:00 pm
5.5 EUR   -0.72%
 SummaryQuotesChartsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
5.42(c) 5.45(c) 5.46(c) 5.54(c) 5.5(c) Last
17 509 6 912 3 261 13 834 8 562 Volume
-0.55% +0.55% +0.18% +1.47% -0.72% Change
More quotes
Financials (EUR)
Sales 2018 50,6 M
EBIT 2018 -0,05 M
Net income 2018 -4,60 M
Debt 2018 10,6 M
Yield 2018 -
Sales 2019 55,3 M
EBIT 2019 1,85 M
Net income 2019 -2,30 M
Debt 2019 8,85 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 1,27x
EV / Sales2019 1,14x
Capitalization 53,9 M
More Financials
Company
Eurobio-Scientific SA engages in the research and commercialization of diagnostic products.Its portfolio consists of proprietary diagnostic products in the following areas: transplantation, infectious diseases and cancer diagnosis.Diaxonhit was founded on October 15, 1997 and is headquartered in... 
More about the company
Surperformance© ratings of Eurobio Scientific
Trading Rating : - Investor Rating :
More Ratings
Latest news on EUROBIO SCIENTIFIC

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/092018 – 1rst JULY :APPOINTMENT OF LOÏC MAUREL TO THE COMPANY’S BOARD OF DI.. 
06/26$ALEHT EUROBIO SCIENTIFIC. Initiation of coverage: A leader in in vitro diag.. 
06/19Martin Jacques: those in America who think they can halt the rise of China ar.. 
04/26Will bourgeoisie ever rule the Chinese state? 'Memoirs of a Chinese Revolut..
1
02/13'Nothing is inevitable in sports. There’s a reason we play the games.' ... A ..
5
More tweets
Qtime:52
Chart EUROBIO SCIENTIFIC
Duration : Period :
Eurobio Scientific Technical Analysis Chart | ALERS | FR0013240934 | 4-Traders
Technical analysis trends EUROBIO SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 6,45 €
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Jean-Michel Carle Chairman-Management Board
Jean-Pierre Hermet Chairman-Supervisory Board
Hervé Duchesne de Lamotte Chief Financial Officer
Michel Picot Member-Supervisory Board
Patrick de Roquemaurel Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EUROBIO SCIENTIFIC0.00%63
CELLTRION, INC.--.--%31 997
IQVIA HOLDINGS INC9.57%22 131
LONZA GROUP9.72%21 465
INCYTE CORPORATION-25.89%14 878
SEATTLE GENETICS, INC.31.68%11 147